Logo image of PRPO

PRECIPIO INC (PRPO) Stock Fundamental Analysis

NASDAQ:PRPO - Nasdaq - US74019L6020 - Common Stock - Currency: USD

9.44  -0.52 (-5.22%)

Fundamental Rating

2

Taking everything into account, PRPO scores 2 out of 10 in our fundamental rating. PRPO was compared to 102 industry peers in the Health Care Providers & Services industry. PRPO has a bad profitability rating. Also its financial health evaluation is rather negative. PRPO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PRPO has reported negative net income.
In the past year PRPO had a positive cash flow from operations.
In the past 5 years PRPO always reported negative net income.
PRPO had negative operating cash flow in 4 of the past 5 years.
PRPO Yearly Net Income VS EBIT VS OCF VS FCFPRPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -17.40%, PRPO is doing worse than 81.37% of the companies in the same industry.
PRPO has a Return On Equity of -26.46%. This is in the lower half of the industry: PRPO underperforms 67.65% of its industry peers.
Industry RankSector Rank
ROA -17.4%
ROE -26.46%
ROIC N/A
ROA(3y)-38.11%
ROA(5y)-41.96%
ROE(3y)-50.29%
ROE(5y)-56.88%
ROIC(3y)N/A
ROIC(5y)N/A
PRPO Yearly ROA, ROE, ROICPRPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 -600 -800

1.3 Margins

The Gross Margin of PRPO (43.83%) is better than 71.57% of its industry peers.
In the last couple of years the Gross Margin of PRPO has grown nicely.
PRPO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.74%
GM growth 5Y42.15%
PRPO Yearly Profit, Operating, Gross MarginsPRPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

3

2. Health

2.1 Basic Checks

PRPO does not have a ROIC to compare to the WACC, probably because it is not profitable.
PRPO has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, PRPO has more shares outstanding
Compared to 1 year ago, PRPO has a worse debt to assets ratio.
PRPO Yearly Shares OutstandingPRPO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M
PRPO Yearly Total Debt VS Total AssetsPRPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

PRPO has an Altman-Z score of -6.15. This is a bad value and indicates that PRPO is not financially healthy and even has some risk of bankruptcy.
PRPO's Altman-Z score of -6.15 is on the low side compared to the rest of the industry. PRPO is outperformed by 90.20% of its industry peers.
PRPO has a debt to FCF ratio of 0.94. This is a very positive value and a sign of high solvency as it would only need 0.94 years to pay back of all of its debts.
PRPO has a Debt to FCF ratio of 0.94. This is amongst the best in the industry. PRPO outperforms 87.25% of its industry peers.
PRPO has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
PRPO has a better Debt to Equity ratio (0.03) than 80.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.94
Altman-Z -6.15
ROIC/WACCN/A
WACC9.09%
PRPO Yearly LT Debt VS Equity VS FCFPRPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

PRPO has a Current Ratio of 0.76. This is a bad value and indicates that PRPO is not financially healthy enough and could expect problems in meeting its short term obligations.
PRPO has a Current ratio of 0.76. This is amonst the worse of the industry: PRPO underperforms 85.29% of its industry peers.
A Quick Ratio of 0.57 indicates that PRPO may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.57, PRPO is doing worse than 84.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.57
PRPO Yearly Current Assets VS Current LiabilitesPRPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 43.90% over the past year.
The Revenue has grown by 26.68% in the past year. This is a very strong growth!
The Revenue has been growing by 42.72% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)43.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.65%
Revenue 1Y (TTM)26.68%
Revenue growth 3Y27.94%
Revenue growth 5Y42.72%
Sales Q2Q%43.62%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PRPO Yearly Revenue VS EstimatesPRPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
PRPO Yearly EPS VS EstimatesPRPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PRPO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PRPO Price Earnings VS Forward Price EarningsPRPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, PRPO is valued a bit cheaper than 60.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.33
EV/EBITDA N/A
PRPO Per share dataPRPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PRPO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PRECIPIO INC

NASDAQ:PRPO (5/30/2025, 8:27:31 PM)

9.44

-0.52 (-5.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-12 2025-05-12
Earnings (Next)08-11 2025-08-11
Inst Owners4.95%
Inst Owner Change33.82%
Ins Owners12.6%
Ins Owner Change3%
Market Cap14.25M
Analysts82.86
Price TargetN/A
Short Float %1.88%
Short Ratio2.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.71
P/FCF 20.33
P/OCF 13.42
P/B 1.22
P/tB 212.75
EV/EBITDA N/A
EPS(TTM)-2.09
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.46
FCFY4.92%
OCF(TTM)0.7
OCFY7.45%
SpS13.26
BVpS7.75
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.4%
ROE -26.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.83%
FCFM 3.5%
ROA(3y)-38.11%
ROA(5y)-41.96%
ROE(3y)-50.29%
ROE(5y)-56.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.74%
GM growth 5Y42.15%
F-Score5
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.94
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.57
Altman-Z -6.15
F-Score5
WACC9.09%
ROIC/WACCN/A
Cap/Depr(3y)15.96%
Cap/Depr(5y)23.27%
Cap/Sales(3y)1.67%
Cap/Sales(5y)3.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.65%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.68%
Revenue growth 3Y27.94%
Revenue growth 5Y42.72%
Sales Q2Q%43.62%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y54.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y109.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y115.24%
OCF growth 3YN/A
OCF growth 5YN/A